Activation of these cells results in the release of a number of chemical mediators, e.g., leukotrienes, cytokines, and proteases, which are responsible for the symptoms of disease and further on lead to epithelial shedding and airway remodeling (33) . Recent investigations have implicated serine proteases as mediators in the pathology of numerous allergic and inflammatory conditions. These effects may be mediated in part by protease-activated receptors (PARs), which can be activated by extracellular serine proteases. However, the underlying molecular mechanisms are still largely unknown (3, 5) .
PARs belong to the superfamily of G protein-coupled receptors that are activated by a specific proteolytic cleavage of their extracellular NH 2 -terminal domain (9, 17, 31, 34) . Cleavage of the receptor unmasks a new sequence at the NH 2 terminus that acts as a so-called tethered ligand, which binds and activates the receptor itself. Molecular cloning has identified four PARs. PAR-1, PAR-3, and PAR-4 are designated thrombin receptors, because they are mainly activated by the serine protease thrombin. PAR-2 is activated by trypsin and in addition by mast cell-derived tryptase (12) . Besides the proteolytic activation, PARs have been shown to be directly activated by short synthetic peptides on the basis of the sequence of the tethered ligand domain. These peptides are therefore useful pharmacological tools for identification and characterization of receptor function.
PARs play important roles in response to injury in several tissues, notably in inflammation and repair (16, 22) . In particular, agonists of PAR-2 have widespread proinflammatory effects. Trypsin, tryptase, and activating peptides cause nitric oxide-dependent vasodilatation (20) , induce extravasation of plasma proteins and infiltration of leukocytes (27, 28) , and stimulate the secretion of proinflammatory neuropeptides (21) . Airway epithelium plays an active role in inflammation through the production of a variety of lipid mediators, cytokines, chemokines, growth factors, and extracellular matrix components. PAR-2 expression, which colocalizes immunohistochemically with trypsin-(ogen) was detected for mouse, rat, guinea pig, and human airway epithelium (4, 7) . Activation of PAR-2 in airway epithelium caused relaxation in mouse and rat airway preparations by the release of a cyclooxygenase product, most probably prostaglandin E 2 , and thus may have a protective role in the airways (4) . On the other hand, PAR-2 activation by trypsin or tc-LIGRLO, a highly specific PAR-2-activating peptide, mediates the release of matrix metalloproteinase (MMP)-9 and eosinophil survival-promoting factor [granulocyte-monocyte colony-stimulating factor (GM-CSF)] from human airway epithelial cells (29, 30) , thus being a critical element in tissue remodeling and eosinophil invasion in asthma and other inflammatory conditions.
On the basis of these results, it became apparent that PAR-2 plays an important role in lung physiology and pathophysiology. Due to the unique activation mechanism of the PARs by proteases, which can cleave within the extracellular NH 2 terminus of the PARs, these may be receptor-activating or -inactivating proteases or may even inhibit activation by preceding proteolysis, depending on the cleavage site. Using different airway epithelial cell lines, a virus-transfected human bronchial epithelial (HBE) cell line and A549 cells, we found that, in both cell lines, trypsin and SLIGKV induced a Ca 2ϩ response with similar characteristics. Furthermore, we investigated the influence of thermolysin, the prototype of the M4 family of metalloproteases (8) . This family M4 comprises several proteases generated by bacteria involved in lung pathology, such as pseudolysin from Pseudomonas aeruginosa or extracellular proteinase A from Legionella pneumophila. Their substrate specificity requires an aromatic amino acid residue in the adjacent COOH-terminal (P1Ј) position of the cleavage site (8) .
We found that thermolysin behaved on HBE cells as both an activating and activation-inhibiting protease, whereas on A549 cells thermolysin was only an inactivating protease. Thus different epithelial cell types display contrasting physiological responses to thermolysin.
MATERIALS AND METHODS
Materials. Thrombin (human), trypsin, thermolysin, hydrocortisone, 3,5,3Ј-triiodothyronine (T 3), epidermal growth factor (EGF), trypsin inhibitor (type I-S: from soybean), and cholera toxin were from Sigma (Deisenhofen, Germany). Pituitary extract was from GIBCO-BRL (Eggenstein, Germany), and insulin-transferrin-sodium selenite (ITS) solution was from Roche Diagnostics (Mannheim, Germany). The cell culture medium Dulbecco's modified Eagle's medium (DMEM)-Ham's nutrient mixture F-12 (1:1), DMEM, fetal calf serum (FCS), and antibiotics (gentamicin, kanamycin, penicillin, and streptomycin) were obtained from Biochrom KG (Berlin, Germany). Fura 2-AM was purchased from Molecular Probes (MoBiTec, Göttingen, Germany). The synthetic thrombin receptor agonist peptide (TRag, Ala-parafluorPhe-Arg-Cha-homoArg-Tyr-NH 2) and human PAR-2-activating peptide (SLIGKV) were from Neosystems Laboratoire (Strasbourg, France); human PAR-3-and PAR-4-activating peptides (TFRGAP and GYPGQV, respectively) were from BACHEM (Heidelberg, Germany).
Cell culture. The HBE cell line, originally established by Yankaskas et al. (36) by transfection of HBE cells with the genes E6 and E7 of the human papilloma virus HPV-18, was kindly provided by Dr. T. Meyer and Prof. Dr. L. Pott (Institut fü r Physiologie, Ruhr-Universitä t Bochum, Germany). For long-term storage, HBE cells were frozen in liquid nitrogen. After thawing, HBE cells were resuspended in DMEMHam's F-12 (1:1) culture medium supplemented with gentamicin (50 g/ml), kanamycin (50 g/ml), ITS (10 g/ml), hydrocortisone (1 M), pituitary extract (3.75 g/ml), EGF (25 ng/ml), T 3 (30 nM), cholera toxin (10 ng/ml), and 10% FCS. A549 cells were cultured in DMEM supplemented with 10% FCS and 100 g/ml penicillin and streptomycin. Cells were kept at 37°C in a humidified atmosphere of 10% CO 2. For the experiments, the cells were grown on round coverslips (22- 30 min at 37°C, supplemented with 2 M fura 2-AM. Loaded cells were transferred into a perfusion chamber with a bath volume of ϳ0.2 ml and mounted on an inverted microscope (Zeiss, Axiovert 135, Jena, Germany). During the experiments, the cells were continuously superfused with medium heated to 37°C. The perfusion system was combined with a six-port valve (Thomachrom, type RH 0112) from Reichelt (Heidelberg, Germany) to allow the switch between solutions containing different agents to be tested.
Single cell fluorescence measurements of [Ca 2ϩ ]i were performed by using an imaging system from T.I.L.L. Photonics (Munich, Germany). Cells were excited alternately at 340 and 380 nm for 25-75 ms at each wavelength with a rate of 0.33 Hz, and the resultant emission was collected above 510 nm. Images were stored on a personal computer, and subsequently the changes in fluorescence ratio (F340 nm/F380 nm) were determined from selected regions of interest covering a single cell.
Characterization of PAR-2 gene expression. Total RNA was isolated and treated with DNAse from cultured HBE and A549 cells with the total RNA isolation kit (RNeasy) from Qiagen (Hilden, Germany). RNA was reverse transcribed, and cDNA was amplified by using primers based on human PAR-1 (accession number M62424, position 473-1,009), PAR-2 (accession number XM003671, position 307-759), PAR-3 (accession number U92971, position 151-663), PAR-4 (accession number XM008930, position 836-1,377), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH). PAR-1 primers (sense, 5Ј-GATCAGCTATTACTTTTCCGGCA-3Ј, antisense 5Ј-TAAT-GCGCAATCAGGAGGACG-3Ј), PAR-2 primers (sense, 5Ј-GAACGAAGAAGAAGCACC-3Ј, antisense, 5Ј-GGAACAGAAA-GACTCCAATG-3Ј), PAR-3 primers (sense, 5Ј-TCCCCTTTT-CTGCCTTGGAAG-3Ј, antisense, 5Ј-AAACTGTTCCCCACAC-CAGTCCAC-3Ј), PAR-4 primers (sense, 5Ј-AACCTCTATGGT-GCCTACGTGC-3Ј, antisense, 5Ј-CCAAGCCCAGCTAATTTT-TG-3Ј), GAPDH primers (sense, 5Ј-ACCACCTGGTGCTCAGT-GTAGCCC-3Ј, antisense, 5Ј-TTCAAAATCAAGTGGGGCGAT-GCT-3Ј) were chosen to amplify a 536-bp fragment for PAR-1, 452-bp fragment for PAR-2, 512-bp for PAR-3, 541-bp for PAR-4, and 600-bp for the internal control GAPDH. The mRNA derived from a human PAR-1, PAR-2, and PAR-3 clone were used as a positive control. PCR conditions were denaturation 15 min at 95°C, 30 cycles at 94°C for 30 s, 55°C for 90 s, 72°C for 60 s, and elongation at 72°C for 10 min. Because the primers used are not flanking an intron, a PCR was performed with the total RNA to exclude any contamination of the RNA with the genomic DNA. The RNA-PCR (40 cycles) carried out was always negative, indicating that the resulting PCR fragments were not amplified from genomic DNA. PCR products were analyzed by Tris-borate-EDTA agarose (1%) gel electrophoresis with ethidium bromide. Documentation was done by using a still video system (Eagle Eye; Stratagene, Heidelberg, Germany).
Immunocytochemistry. HBE cells grown on coverslips were washed three times in phosphate-buffered saline (PBS) and subsequently fixed at Ϫ20°C in methanol for 15 min. After fixation, the cells were washed three times in PBS and permeabilized with 1% Triton X-100 in PBS for 15 min. Again the cells were washed in PBS. Before addition of the anti-PAR-2 antiserum, the cells were incubated for 30 min in PBS supplemented with 1% BSA. Cells were incubated in primary antibody solution 20 g/ml overnight at 4°C. The affinitypurified goat polyclonal antibody to PAR-2 was purchased from Santa Cruz Biotechnology (Heidelberg, Germany). After incubation with the primary antibody, the cells were washed three times in PBS, then incubated in 4 g/ml of donkey anti-goat IgG conjugated to horseradish peroxidase (Santa Cruz Biotechnology) for 5 h at room temperature. After secondary antibody incubation, the cells were washed three times in PBS and incubated in diaminobenzidine (DAB) for 10 min. After the DAB staining, cells were rinsed with H 2O for 5 min and counterstained with hematoxylin for 1 min, rinsed again with H 2O, dehydrated, and then mounted in Entellan (Merck, Darmstadt, Germany). Observations of the cultured cells were performed on a Zeiss LSM 510 laserscanning confocal microscope.
RESULTS

RT-PCR and immunocytochemistry.
The RT-PCR methodology was used to detect the mRNA expression of all four PARs in the HBE and A549 cell lines. Therefore, total mRNA was extracted. As shown in Fig.  1A , cultured HBE and A549 cells express only PAR-2 mRNA. We did not see a PCR fragment corresponding to PAR-1, PAR-3, and PAR-4 (data not shown). As an internal control for the RT-PCR conditions, the mRNA for GAPDH was detected by primers specific for this gene product.
To determine the PAR-2 expression on the protein level, a polyclonal antibody specific for human PAR-2 was used, and immunocytochemical staining was performed. Confocal microscopy allowed us to localize the PAR-2 in HBE and A549 cells with prevalence for the plasma membrane, as shown in Fig. 1B .
Characteristics of PAR-2-evoked Ca 2ϩ response. After identifying the presence of PAR-2 mRNA and protein in HBE and A549 cells, we continuously monitored [Ca 2ϩ ] i in fura 2-AM-loaded epithelial cells, stimulated with either the serine protease trypsin or the PAR-2-activating peptide (SLIGKV). A brief (60 s) addition of trypsin (50 nM) or SLIGKV (100 M) induced a transient change in [Ca 2ϩ ] i in both cell lines, as shown in Fig. 2, A and B sufficient to inhibit Ca 2ϩ influx as well as prolonged Ca 2ϩ signaling in HBE cells (data not shown). Analysis of the concentration-effect curves clearly demonstrated for HBE cells that 1) the amplitude of the initial transient did not depend on external Ca 2ϩ , 2) the PAR-2-activating peptide (SLIGKV) was about 10,000 times less effective, and 3) the maximal amplitude evoked by the peptide was lower than the Ca 2ϩ response elicited by proteolytic activation of the receptor (Fig. 3) . In the absence of extracellular Ca 2ϩ , emptying of intracellular Ca 2ϩ stores by cyclopiazonic acid (10 M), an inhibitor of the Ca 2ϩ -ATPase of the sarco-/endoplasmic reticulum, completely abolished a subsequent Ca 2ϩ response elicited by trypsin (not shown).
By definition, proteases activate PARs by proteolytic cleavage of the NH 2 -terminal exodomain, whereas the activating peptides, resembling the tethered ligand domain, activate the receptor without proteolytic cleavage. Consequently, we tested whether the trypsin inhibitor could prevent cell activation by the protease without influencing the peptide-elicited response. In the presence of soybean trypsin inhibitor, the Ca response induced by trypsin (Fig. 4A) , but not by SLIGKV (Fig. 4B) , was completely abolished in HBE (left) and A549 cells (right).
For further characterization of the PAR-2-evoked Ca 2ϩ response, we wanted to elucidate the underlying signal transduction pathway of PAR-2 activation. First, we investigated the influence of U-73122, a well characterized inhibitor of phospholipase C (PLC). (Fig. 5B ) completely abolished the Ca 2ϩ response evoked by the protease. However, when we used the inactive analog U-73343 (10 M) in the same experimental protocol, the intracellular Ca 2ϩ signal was not affected (Fig. 5C) . Similar results were obtained by using SLIGKV instead of trypsin as agonist (results not shown). The membrane-permeant inositol 1,4,5-trisphosphate receptor (InsP 3 R) antagonist 2-aminoethoxydiphenyl borate (2-APB) proved to be an effective probe for assessing InsP 3 R involvement in the Ca 2ϩ signaling in situ (10) . As also shown in Fig. 5 , the Ca 2ϩ signal elicited by trypsin (Fig. 5A ) in HBE (left) and A549 cells (right) was completely inhibited by preincubation (30 min) with 2-APB (300 M) (Fig. 5D ) for the respective cell lines. Again, the same was observed by using the agonist peptide SLIGKV (data not shown). To elucidate the involvement of pertussis toxin (PTX)-sensitive or PTX-insensitive G proteins in coupling PAR-2 to PLC activation, epithelial cells were treated for 24 h with 100 ng/ml of PTX. The pretreatment of HBE and A549 cells with PTX did not influence the trypsin-elicited Ca 2ϩ response in HBE but attenuated the response induced in A549 cells ( Table 1 ), indicating that only in HBE cells does PAR-2 couple solely to PTX-insensitive G proteins.
The family of PARs consists of four members that are activated by thrombin (PAR-1, PAR-3, and PAR-4) and trypsin (PAR-2 and PAR-4). To confirm the RT-PCR data and to evaluate whether HBE and A549 cells besides PAR-2 functionally express other members of the PAR-family, the cell lines were challenged with thrombin. However, superfusion of the epithelial cells with 0.1 U/ml of thrombin, which represents a saturating concentration used to induce a Ca 2ϩ signal mediated through the activation of PAR-1, PAR-3, and PAR-4 in primary cultures of rat astrocytes (32) , was ineffective in eliciting a Ca 2ϩ response in the epithelial cell lines (Fig. 6) . Similar results were obtained on HBE cells with higher concentrations of thrombin (up to 3 U/ml) and 1 M TRag and 100 M PAR-3-and PAR-4-activating peptides (data not shown).
Effect of cathepsin G and thermolysin on PAR-2-mediated Ca
2ϩ response. Due to the unique activation mechanism of PARs, proteases that cleave the receptor at a site apart from the tethered ligand domain can act as activation-inhibiting proteases. Previous experiments in our laboratory revealed that the proteases cathepsin G and thermolysin could cleave PAR-1 in rat astrocytes, leaving the cells unresponsive to a subsequent stimulation by thrombin (25, 26) . Similarly, in HBE and A549 cells we tested whether these proteases could influence the signaling mediated by activation of PAR-2. Superfusion of epithelial cells with 100 nM cathepsin G neither influenced the resting Ca 2ϩ level nor altered the trypsin-evoked Ca 2ϩ signal in HBE and A549 cells (data not shown). In contrast, as shown in Fig. 7 , thermolysin (0.05-5 U/ml) induced a transient, concentration-dependent rise of [Ca 2ϩ ] i in HBE cells (Fig. 7, B and C, left) . In the same way it abolished the response to a subsequent exposure to 50 nM trypsin, whereas the response to a subsequent addition of SLIGKV (100 M) was not altered (Fig. 7D) .
In contrast to the situation found with HBE cells, in A549 cells, thermolysin was not able to elicit a Ca 2ϩ response but abolished the cellular responsiveness to a subsequent addition of trypsin (Fig. 7, B and C, right) . It did not affect the activation by SLIGKV (Fig. 7D) . On the basis of these findings, one can deduce that thermolysin can play a dual role: it cleaves PAR-2 associ- The values given are means Ϯ SE of the amplitude, derived from maximal change above basal value of the ratio. Human bronchial epithelial (HBE) and A549 cells were preincubated for 24 h with 100 ng/ml of pertussis toxin (PTX). Responses were evoked by the addition of 50 nM trypsin in nontreated cells (control) and PTX-treated cells. n, Number of cells in parentheses.
ated with receptor activation in HBE cells, but without activation in A549 cells. The protease leaves cells from both lines unresponsive to an additional challenge with trypsin, whereas the agonist peptide was still effective.
DISCUSSION
Recently, PAR-2 activation has been shown to cause relaxation of airway preparations from human, mouse, rat, and guinea pig by the release of a cyclooxygenase product from the epithelium (4), which demonstrates a protective role for PAR-2 in airway epithelial cells. In addition, trypsin and PAR-2-activating peptides were shown to induce the release of MMP-9 and eosinophil survival-promoting factor (GM-CSF) in A549, a human airway epithelial cell line and primary cultures of small airway epithelial cells (29, 30) . Thus it is important to understand the signaling events leading to these physiological consequences of PAR-2 activation, which are still elusive.
In this study, we clearly demonstrate the functional expression of PAR-2 in HBE and A549 cells, two cell lines of human airway epithelium origin. The failure of thrombin to induce a Ca 2ϩ signal indicates that the lung epithelial cells tested do not express other members of the PAR family coupled to intracellular Ca 2ϩ signals. In this respect, the epithelial cells strongly differ from isolated astrocytes, which were shown by us to express all four PAR subtypes (26, 32) . This is consistent with the ubiquitous but distinct distribution of all four PARs in the whole brain, as our group demonstrated recently in a study that systematically investigated the occurrence of PARs in the brain (23) . The study also showed that activation of different PARs in astrocytes may evoke different physiological signaling and lead to distinct downstream events with respect to either proliferation or cytotoxicity (32), providing useful insights into the role of PARs in the processes of protection and degeneration of neuronal tissue.
PAR-2 activation in the epithelial cells elicited a Ca 2ϩ response, which was partially PTX sensitive in A549 cells, but completely PTX resistant in HBE cells. The Ca 2ϩ rise is transduced via PLC activation to InsP 3 -mediated release of Ca 2ϩ from intracellular stores. The lower efficacy of the soluble peptide ligand compared with that of the tethered ligand that we have observed here is a well-documented characteristic of PARs (18, 31) . The fact that the amplitude of the PAR-2-evoked Ca 2ϩ response showed no dependence on extracellular Ca 2ϩ confirms that the initial PAR-2 activation is exclusively coupled to the release of Ca 2ϩ from internal stores.
Immunocytochemical studies revealed an abundant PAR-2 expression in the lung and the airways, especially the epithelium and the smooth muscle (7), but the physiological functions and the endogenous ligands that activate PAR-2 are still poorly understood. Trypsin immunoreactivity has been identified in airway epithelium (4) , and a trypsin-like protease was purified from human airways (35) . It can be speculated that this airway-derived, trypsin-like protease may be able to activate PAR-2. On the other hand, tryptase from mast cells, which was shown to activate PAR-2 in human vascular endothelial cells and human lung fibroblasts (1, 12) , might be an important endogenous protease able to stimulate PAR-2 activation in bronchial epithelial cells. This is of special interest because mast cells infiltrate the inflamed airway wall. Moreover, recent biological and immunological investigations have implicated tryptase released from mast cells as a mediator in the pathology of numerous allergic and inflammatory conditions, such as asthma (2) or neurogenic inflammation processes (21) .
A consequence of PAR-2 activation might also be the induction of an inflammatory response in the airways. This suggestion seems to contradict the protective effects observed for epithelial PAR-2 in bronchial rings (4) . However, initial inflammatory reactions have a protective function. Only persistent inflammation leads to pathological reactions. Therefore, it could be possible that the consequence of PAR-2 activation, whether it is cytoprotective or deleterious, strongly depends on the protease concentration or the duration of the exposure to protease. Indeed, such behavior was found for thrombin-induced PAR-1 activation in the hippocampus (22) . That study showed that low doses of thrombin increased cell survival after experimental ischemia in organotypic hippocampal slice culture. The protease thrombin by itself applied at higher concentrations even potentiated cell death after ischemia.
A physiologically controlled activation of PAR-2 might evoke mechanisms that are protective for the lung. On the other hand, uncontrolled activation of PAR-2, via other proteases, probably causes the induction of pathophysiological reactions leading to cell death. Therefore, it is of special interest to investigate the capacity of other proteases to activate PAR-2 or to inhibit activation. Two airborne dust mite antigens, the serine proteases Der p3 and Der p9, were found to activate PAR-2 in lung epithelial cells (24) . It is documented that in addition to trypsin, tryptase and the lung human airway trypsin-like protease can activate PAR-2 (11). For PAR-1 in astrocytes we found that treatment with thermolysin, which is known to cleave the corresponding tethered ligand, generated a thrombin-insensitive receptor, whereas the response to the activating peptide was not affected (25) . From our data in that study, we could establish a novel model for PAR-1 inactivation, which implies that, after proteolytic or nonproteolytic agonist activation of the receptor, an additional, still unidentified protease physiologically terminates the signal. However, in contrast to PAR-1, little has been reported so far in the literature about proteases inhibiting activation of PAR-2 (19) . Therefore, we tested the serine protease cathepsin G and the thermophilic bacterial protease thermolysin on PAR-2 in airway epithelial cells. Prior addition of cathepsin G failed to alter the trypsin-induced Ca 2ϩ response in the epithelial cell lines. Thermolysin is the prototype of a family of zinc metalloproteases comprising only secreted eubacterial endopeptidases from both gram-positive and gramnegative bacteria (8) . Using thermolysin, we obtained apparently contradictory results. In HBE as well as in A549 cells, prior addition of thermolysin leaves the cells unresponsive to a subsequent challenge with trypsin but not the PAR-2-activating peptide SLIGKV. So far, these results indicate that, similar to PAR-1 (25, 26) , thermolysin cleaves the receptor in such a way that the tethered ligand domain is destroyed.
However, thermolysin seems to play a dual role in lung epithelia. Thermolysin has also been found here to have the potency to evoke a concentration-dependent increase of [Ca 2ϩ ] i via activation of PAR-2. The latter was seen only in HBE cells, not A549 cells. This finding strongly suggests that either there is a structural difference between PAR-2 expressed in HBE and in A549 cells, or thermolysin activates a protein, expressed only in HBE cells, that helps as an agonist for PAR-2. In the literature, examples for both possibilities have been reported. Recently, a polymorphic PAR-2 was detected, displaying a reduced sensitivity to trypsin and differential responses to PAR agonist peptides (6) . This polymorphic form of human PAR-2 was identified by a phenylalanine to serine mutation at residue 240 within extracellular loop 2. Interestingly, extracellular loop 2 is suggested to be important for the interaction with the tethered ligand and therefore governing agonist specificity and receptor signaling (14, 15) . This report demonstrates that minor changes in the amino acid sequence of PARs can lead to significant changes in the receptor structure, causing a dramatic switch in the sensitivity toward proteases and/or peptide agonists. On the other hand, elegant studies coexpressing human PAR-3 and PAR-4 in fibroblasts, derived from PAR-1 knockout mice, strongly suggested a coactivation mechanism, whereby the activation of PAR-3 by thrombin promotes the activation of PAR-4 (13) . Similarly, one could postulate that in HBE cells thermolysin could activate a "sleeping" agonist activating PAR-2. In the future, it will be an interesting task to investigate the cellular consequences of the physiological polymorphism observed here to better understand the role of PARs in the physiology and pathophysiology of the airway epithelium.
